Skip to main content
. Author manuscript; available in PMC: 2017 Jul 6.
Published in final edited form as: Curr Opin Hematol. 2016 Jul;23(4):434–443. doi: 10.1097/MOH.0000000000000261

Figure 3. Co-occurrence of frequent mutations in AITL.

Figure 3

(a) Analysis of the mutational status of RHOA G17V, TET2, DNMT3A and IDH2 in a cohort of 120 AITL (information extracted from published data (61–64)). Each column represents a patient sample; each row represent mutations in each of the genes of interest. (b) Quantification of the co-occurrence of mutations in RHOA G17V and epigenetic regulators. In the column on the right are represented the cases mutated for RHOA G17V, TET2, DNMT3A and IDH2 R172; on the upper row the co-occurrence indicated by the number of cases on the left category that also carry the mutation in the genes indicated on the top (n) and the percentage of co-occurrence calculated from the total number of cases [(%) in bold].